Offermanns, Stefan Pharmacology, Max Planck Institute for Heart and Lung Research, Max Planck Society;
Wannick, M., Assmann, J. C., Vielhauer, J. F., Offermanns, S., Zillikens, D., Sadik, C. D., et al. (2018). The Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation. FRONTIERS IN IMMUNOLOGY, 9: 1890. doi:10.3389/fimmu.2018.01890.